EAU 2022: Recurrent Prostate Cancer: PSMA in Staging for Recurring Prostate Cancer

EAU 2022 modern diagnostic and therapeutic approaches in prostate cancer, staging of recurrent prostate cancer, 68Ga-labelled PSMA ligand as a superior PET tracer for the diagnosis of prostate cancer compared to 18F-choline PET, PSMA PET/CT recommendations for PSA recurrence after radical prostatectomy.

Read the full article here

Related Articles